Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension


Autoria(s): CERON, C. S.; CASTRO, M. M.; RIZZI, E.; MONTENEGRO, M. F.; FONTANA, V.; SALGADO, M. C. O.; GERLACH, R. F.; TANUS-SANTOS, J. E.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Background and purpose: Increased oxidative stress and up-regulation of matrix metalloproteinases (MMPs) may cause structural and functional vascular changes in renovascular hypertension. We examined whether treatment with spironolactone (SPRL), hydrochlorothiazide (HCTZ) or both drugs together modified hypertension-induced changes in arterial blood pressure, aortic remodelling, vascular reactivity, oxidative stress and MMP levels and activity, in a model of renovascular hypertension. Experimental approach: We used the two-kidney,one-clip (2K1C) model of hypertension in Wistar rats. Sham-operated or hypertensive rats were treated with vehicle, SPRL (25 mg center dot kg-1 center dot day-1), HCTZ (20 mg center dot kg-1 center dot day-1) or a combination for 8 weeks. Systolic blood pressure was monitored weekly. Aortic rings were isolated to assess endothelium-dependent and -independent relaxations. Morphometry of the vascular wall was carried out in sections of aorta. Aortic NADPH oxidase activity and superoxide production were evaluated. Formation of reactive oxygen species was measured in plasma as thiobarbituric acid-reactive substances. Aortic MMP-2 levels and activity were determined by gelatin and in situ zymography, fluorimetry and immunohistochemistry. Key results: Treatment with SPRL, HCTZ or the combination attenuated 2K1C-induced hypertension, and reversed the endothelial dysfunction in 2K1C rats. Both drugs or the combination reversed vascular aortic remodelling induced by hypertension, attenuated hypertension-induced increases in oxidative stress and reduced MMP-2 levels and activity. Conclusions and implications: SPRL or HCTZ, alone or combined, exerted antioxidant effects, and decreased renovascular hypertension-induced MMP-2 up-regulation, thus improving the vascular dysfunction and remodelling found in this model of hypertension.

CAPES Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Identificador

BRITISH JOURNAL OF PHARMACOLOGY, v.160, n.1, p.77-87, 2010

0007-1188

http://producao.usp.br/handle/BDPI/26217

10.1111/j.1476-5381.2010.00678.x

http://dx.doi.org/10.1111/j.1476-5381.2010.00678.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

British Journal of Pharmacology

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #hydrochlorothiazide #matrix metalloproteinases #reactive oxygen species #renovascular hypertension #spironolactone #SMOOTH-MUSCLE-CELLS #ANGIOTENSIN-II #OXIDATIVE STRESS #LARGE ARTERIES #NADPH OXIDASE #GROWTH-FACTOR #RHO-KINASE #RATS #ALDOSTERONE #INVOLVEMENT #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion